168 related articles for article (PubMed ID: 38497192)
1. Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods.
Biskupiak J; Oderda G; Brixner D; Wandstrat TL
J Comp Eff Res; 2024 May; 13(5):e230041. PubMed ID: 38497192
[No Abstract] [Full Text] [Related]
2. Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.
Bergese S; Berkowitz R; Rider P; Ladouceur M; Griffith S; Segura Vasi A; Cochrane K; Wase L; Demitrack MA; Habib AS
Pain Res Manag; 2020; 2020():7492865. PubMed ID: 33163127
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.
Ayad S; Demitrack MA; Burt DA; Michalsky C; Wase L; Fossler MJ; Khanna AK
Clin Drug Investig; 2020 Aug; 40(8):755-764. PubMed ID: 32583295
[TBL] [Abstract][Full Text] [Related]
4. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery.
Goodarzi M
Paediatr Anaesth; 1999; 9(5):419-22. PubMed ID: 10447905
[TBL] [Abstract][Full Text] [Related]
6. Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden.
Oderda GM; Senagore AJ; Morland K; Iqbal SU; Kugel M; Liu S; Habib AS
J Pain Palliat Care Pharmacother; 2019; 33(3-4):82-97. PubMed ID: 31609155
[TBL] [Abstract][Full Text] [Related]
7. Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.
Gan TJ; Wase L
Drugs Today (Barc); 2020 Apr; 56(4):269-286. PubMed ID: 32309822
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Hydromorphone for cancer pain.
Li Y; Ma J; Lu G; Dou Z; Knaggs R; Xia J; Zhao S; Dong S; Yang L
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011108. PubMed ID: 34350974
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oliceridine treatment in patients with postoperative pain: a systematic review and meta-analysis of randomized controlled trials.
Niu J; Hu W; Lu Y; Tang H
Expert Rev Clin Pharmacol; 2023; 16(6):589-599. PubMed ID: 37171148
[TBL] [Abstract][Full Text] [Related]
12. Side Effect Rates of Opioids in Equianalgesic Doses via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis.
Dinges HC; Otto S; Stay DK; Bäumlein S; Waldmann S; Kranke P; Wulf HF; Eberhart LH
Anesth Analg; 2019 Oct; 129(4):1153-1162. PubMed ID: 30418234
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 May; 244(10):1164-9. PubMed ID: 24786163
[TBL] [Abstract][Full Text] [Related]
14. Oliceridine for the Management of Acute Postoperative Pain.
Liu Y; Hu Q; Yang J
Ann Pharmacother; 2021 Oct; 55(10):1283-1289. PubMed ID: 33423508
[TBL] [Abstract][Full Text] [Related]
15. A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain.
Viscusi ER; Grond S; Ding L; Danesi H; Jones JB; Sinatra RS
Pain Manag; 2016; 6(1):19-24. PubMed ID: 26376128
[TBL] [Abstract][Full Text] [Related]
16. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK
J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210
[TBL] [Abstract][Full Text] [Related]
17. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Wirz S; Wartenberg HC; Nadstawek J
Support Care Cancer; 2008 Sep; 16(9):999-1009. PubMed ID: 18095008
[TBL] [Abstract][Full Text] [Related]
18. A critical review of oliceridine injection as an IV opioid analgesic for the management of severe acute pain.
Viscusi ER
Expert Rev Neurother; 2022 Jun; 22(6):419-426. PubMed ID: 35502668
[TBL] [Abstract][Full Text] [Related]
19. Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults.
Jin Z; Zhu M; Gupta A; Page C; Gan TJ; Bergese SD
Expert Opin Pharmacother; 2022 Jan; 23(1):9-17. PubMed ID: 34534033
[TBL] [Abstract][Full Text] [Related]
20. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
